Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee approves amended 340B reporting bill after hours of testimony from hospitals, FQHCs and industry groups
Summary
The House Public Health Committee voted 11-0 to advance an amended Senate Bill 118 on 340B program reporting and transparency after testimony from hospital systems, federally qualified health centers and industry representatives about how savings are used and how contract pharmacies operate.
The House Public Health Committee on Wednesday advanced an amended version of Senate Bill 118, a measure that would require greater reporting about covered entities’ participation in the federal 340B drug pricing program. The committee voted to pass the bill as amended by voice and roll call, 11-0.
The bill’s supporters and neutral testifiers — including hospital systems, community health centers and pharmacy associations — told the committee they support transparency but asked the lawmakers to protect the operations of federally qualified health centers (FQHCs) and other small safety-net providers. Dawn Moore, vice president and chief pharmacy officer at Community Health Network, testified on behalf of the Indiana Hospital Association and Indiana Pharmacy Association and said, “We are neutral on Senate Bill 118,” and that the accepted amendments carve out HRSA grantees and many FQHCs from parts of the reporting language.
Nut Graf: Committee members said their goal is transparency about how 340B savings are generated and used; stakeholders…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
